Hepatitis C antibody after kidney transplantation: clinical significance.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  American Journal of Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000168615PMID 7692726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus infection in kidney transplant patients.

  1992cited by this paper
• Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.

  1992cited by this paper
• Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

  1992cited by this paper
• Antibody to hepatitis C virus and liver disease in volunteer blood donors.

  1991cited by this paper
• Organ transplantation and hepatitis C virus infection.

  1991cited by this paper
• Detection of antibody to hepatitis C virus in renal transplant recipients.

  1991cited by this paper
• Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

  1991cited by this paper
• Second generation (RIBA) test in diagnosis of chronic hepatitis C.

  1991cited by this paper
• Role of hepatitis C virus in non-B chronic liver disease.

  1991cited by this paper
• Transmission of hepatitis C virus by organ transplantation.

  1991cited by this paper
• HEPATITIS C IN RENAL TRANSPLANT RECIPIENTS

  1991cited by this paper
• Hepatitis C virus infection among kidney transplant recipients.

  1991cited by this paper
• Second generation tests in diagnosis of chronic hepatitis C.

  1991cited by this paper
• Kidney transplants with positive anti-hepatitis C virus donors.

  1990cited by this paper
• High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.

  1990cited by this paper
• Hepatitis C antibody and chronic liver disease in haemophilia.

  1990cited by this paper
• Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

  1990cited by this paper
• Prevalence and significance of anti-HCV antibodies in kidney graft recipients.

  1990cited by this paper
• Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.

  1990cited by this paper
• Hepatitis C infection in two urban hemodialysis units.

  1990cited by this paper
• Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity.

  1990cited by this paper
• [Hepatitis C virus infection in patients treated with hemodialysis].

  1990cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease.

  1989cited by this paper
• Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

  1989cited by this paper
• Hepatitis C virus antibody.

  1989cited by this paper
• Hepatitis C virus antibodies among risk groups in Spain.

  1989cited by this paper
• Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.

  1989cited by this paper
• Is renal transplantation involved in post-transplantation liver disease? A prospective study.

  1980cited by this paper
• Etiology of liver disease in renal-transplant patients.

  1979cited by this paper

• Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

  2000cites this paper
• Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C.

  1999cites this paper
• Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?

  1998cites this paper
• Renal transplantation in patients positive for hepatitis B or C (pro).

  1998cites this paper
• Effect of interferon-alfa treatment in renal transplant recipients with chronic hepatitis C.

  1998cites this paper
• Hepatitis C virus and renal transplantation

  1998cites this paper
• Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.

  1998cites this paper
• Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.

  1997cites this paper
• The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients.

  1996cites this paper
• Increased detection of antibody to hepatitis C virus in renal transplant patients by third-generation assays.

  1996cites this paper
• Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.

  1996cites this paper
• Histopathological features of hepatitis C virus infection in patients with chronic renal failure and renal transplantation.

  1996cites this paper
• Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.

  1995cites this paper
• Hepatitis C virus infection and disease in renal transplantation.

  1995cites this paper
• Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.

  1995cites this paper
• Liver function tests in hepatitis C virus infected kidney transplant recipients.

  1995cites this paper
• Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation.

  1995cites this paper
• Hepatitis C following renal transplantation: histopathological correlations.

  1995cites this paper
• Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.

  1995cites this paper